Actively Recruiting
STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)
Led by The Society of Thoracic Surgeons · Updated on 2022-08-25
16000
Participants Needed
1
Research Sites
1200 weeks
Total Duration
On this page
Sponsors
T
The Society of Thoracic Surgeons
Lead Sponsor
A
American College of Cardiology
Collaborating Sponsor
AI-Summary
What this Trial Is About
The TVT Registry™ is a benchmarking tool developed to track patient safety and real-world outcomes related to the transcatheter aortic valve replacement (TAVR) procedure. Created by The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC), the TVT Registry is designed to monitor the safety and efficacy of this new procedure for the treatment of aortic stenosis.
CONDITIONS
Official Title
STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years or older
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
American College of Cardiology
Washington D.C., District of Columbia, United States, 20037
Actively Recruiting
Research Team
J
Joan Michaels
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here